Similar safety after TAVR, surgery in lower-risk ‘real-world’ patients
For patients at low-to-intermediate risk, transfemoral TAVR is a safe alternative to surgery, with comparable survival at 1 year, according to a large registry study.For the OBSERVANT trial, Marco Barbanti, MD, of Ferrarotto Hospital (Catania, Italy), and colleagues looked at 7,618 Italian patients with aortic stenosis and low-to-intermediate surgical risk who underwent either surgery (n […]
